These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 10358028)
1. 20-Epi analogues of 1,25-dihydroxyvitamin D3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D3 receptor. Yang W; Freedman LP J Biol Chem; 1999 Jun; 274(24):16838-45. PubMed ID: 10358028 [TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. Kim S; Shevde NK; Pike JW J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825 [TBL] [Abstract][Full Text] [Related]
3. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element. Imai Y; Pike JW; Koeffler HP Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077 [TBL] [Abstract][Full Text] [Related]
4. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system. Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382 [TBL] [Abstract][Full Text] [Related]
5. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements. Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990 [TBL] [Abstract][Full Text] [Related]
6. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions. Herdick M; Steinmeyer A; Carlberg C Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341 [TBL] [Abstract][Full Text] [Related]
7. Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in vitamin D receptor transactivation during keratinocyte differentiation. Oda Y; Sihlbom C; Chalkley RJ; Huang L; Rachez C; Chang CP; Burlingame AL; Freedman LP; Bikle DD Mol Endocrinol; 2003 Nov; 17(11):2329-39. PubMed ID: 12893881 [TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M; Freedman LP; Li H; Christakos S Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705 [TBL] [Abstract][Full Text] [Related]
9. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor. Liu YY; Nguyen C; Peleg S Mol Endocrinol; 2000 Nov; 14(11):1776-87. PubMed ID: 11075811 [TBL] [Abstract][Full Text] [Related]
10. Distinct conformational changes induced by 20-epi analogues of 1 alpha,25-dihydroxyvitamin D3 are associated with enhanced activation of the vitamin D receptor. Peleg S; Sastry M; Collins ED; Bishop JE; Norman AW J Biol Chem; 1995 May; 270(18):10551-8. PubMed ID: 7737990 [TBL] [Abstract][Full Text] [Related]
12. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex. Barletta F; Freedman LP; Christakos S Mol Endocrinol; 2002 Feb; 16(2):301-14. PubMed ID: 11818502 [TBL] [Abstract][Full Text] [Related]
14. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3. Miura D; Manabe K; Ozono K; Saito M; Gao Q; Norman AW; Ishizuka S J Biol Chem; 1999 Jun; 274(23):16392-9. PubMed ID: 10347199 [TBL] [Abstract][Full Text] [Related]
15. Gene regulatory potential of 1alpha,25-dihydroxyvitamin D(3) analogues with two side chains. Bury Y; Herdick M; Uskokovic MR; Carlberg C J Cell Biochem Suppl; 2001; Suppl 36():179-90. PubMed ID: 11455583 [TBL] [Abstract][Full Text] [Related]
16. Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor. Liu YY; Collins ED; Norman AW; Peleg S J Biol Chem; 1997 Feb; 272(6):3336-45. PubMed ID: 9013574 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors. Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913 [TBL] [Abstract][Full Text] [Related]
18. The autonomous transactivation domain in helix H3 of the vitamin D receptor is required for transactivation and coactivator interaction. Kraichely DM; Collins JJ; DeLisle RK; MacDonald PN J Biol Chem; 1999 May; 274(20):14352-8. PubMed ID: 10318858 [TBL] [Abstract][Full Text] [Related]
19. Resistance of HBL100 human breast epithelial cells to vitamin D action. Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184 [TBL] [Abstract][Full Text] [Related]
20. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes. Ellison TI; Eckert RL; MacDonald PN J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]